Oral immunotherapies in MS a comparison of efficacy. - a podcast by BMJ Group

Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831

Further episodes of JNNP podcast

Further podcasts by BMJ Group

Website of BMJ Group